AngioDynamics
ANGO
134 hedge funds and large institutions have $722M invested in AngioDynamics in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 56 reducing their positions, and 14 closing their positions.
0.73% less ownership
Funds ownership: 97% → 96.27% (-0.73%)
7% less funds holding
Funds holding: 144 → 134 (-10)
11% less capital invested
Capital invested by funds: $810M → $722M (-$87.3M)
13% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 56
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$7.81M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.98M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$2.75M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.67M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$7.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.47M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.74M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$2.27M |
| 5 |
Millennium Management
New York
|
-$2.23M |
ANGO Hedge Fund Activity: Q2 2022 in Review
134 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2022, worth a combined $722M — down 11% from $810M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ANGO and 9 opened new positions — a net loss of 5 holders — while 56 trimmed existing stakes and 49 added.
The largest buyer was Polar Asset Management Partners, adding an estimated $7.81M. The largest seller was Soleus Capital Management, cutting an estimated $7.3M.
- 134 institutional investors held AngioDynamics (ANGO) as of Q2 2022, down from 144 in Q1 2022.
- Funds reported $722M of AngioDynamics stock for Q2 2022, down 11% quarter-over-quarter.
- 9 funds opened new AngioDynamics positions in Q2 2022 and 14 closed out, a net change of -5 holders.
- The largest AngioDynamics buyer in Q2 2022 was Polar Asset Management Partners, an estimated $7.81M added.
- The largest AngioDynamics seller in Q2 2022 was Soleus Capital Management, an estimated $7.3M sold.
Based on aggregated 13F filings for Q2 2022.